Identifies circRNAs that affect cancer outcomes in colorectal cancer, implying their potential as biomarkers and therapies.
This study identifies hsa_circ_0039776 and hsa_circ_0067353 as novel tumor-suppressive circRNAs exhibiting reduced expression in colorectal cancer spheroids and metastatic lesions. The constructed circRNA-miRNA-mRNA regulatory network indicates that these circRNAs modulate oncogenic miRNAs (hsa-miR-614, hsa-miR-645, hsa-miR-4689) and their downstream tumor-suppressive targets (CCL5, INSC, SLC9A1, SLC34A1), which correlate with favorable survival outcomes and influence cancer stemness. These results contribute to a deeper comprehension of the role of circRNAs in the pathogenesis of colorectal cancer and underscore their potential utility as diagnostic biomarkers and therapeutic targets.
No takes yet. Share an insight, caveat, or question.
Su et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: